⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
Recover Investment Losses: Class Action Initiated Against MoonLake Immunotherapeutics (MLTX)
accessnewswire.com
MLTX
Pomerantz LLP Issues Alert Regarding Shareholder Class Action Involving MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Levi & Korsinsky Moves to SueWallSt For MoonLake Immunotherapeutics Investors That Lost Money
accessnewswire.com
MLTX
MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prnewswire.com
MLTX
MLTX CLASS ACTION: The MoonLake Immunotherapeutics Securities Fraud Class Action Deadline is Approaching; Investors Notified to Contact BFA Law by December 15
accessnewswire.com
MLTX
Contact Levi & Korsinsky by December 15, 2025 to Join Class Action Against MoonLake Immunotherapeutics (MLTX)
accessnewswire.com
MLTX
Levi & Korsinsky Urges MoonLake Immunotherapeutics (MLTX) Shareholders to Act Before Lead Plaintiff Deadline December 15, 2025
accessnewswire.com
MLTX
Shareholders of MoonLake Immunotherapeutics (MLTX): Protect Your Rights Before December 15, 2025 - Contact Levi & Korsinsky
accessnewswire.com
MLTX
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
prnewswire.com
MLTX
MoonLake Immunotherapeutics Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MLTX
prnewswire.com
MLTX